<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fumakia</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Ho</surname>
    <given-names>E. A.</given-names>
   </name>
  </person-group> (
  <year>2016</year>). 
  <article-title>Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction</article-title>. 
  <source>Rev. Med. Virol.</source>
  <volume>26</volume> (
  <issue>1</issue>), 
  <fpage>4</fpage>â€“
  <lpage>20</lpage>. 
  <pub-id pub-id-type="doi">10.1002/rmv.1853</pub-id>
  <pub-id pub-id-type="pmid">26308574</pub-id>
 </mixed-citation>
</ref>
